Investigational Drug Information for Vanoxerine
✉ Email this page to a colleague
What is the drug development status for Vanoxerine?
Vanoxerine is an investigational drug.
There have been 3 clinical trials for Vanoxerine.
The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2015.
The most common disease conditions in clinical trials are Atrial Fibrillation, Cocaine-Related Disorders, and Atrial Flutter. The leading clinical trial sponsors are Laguna Pharmaceuticals, Inc., University of Texas, and National Institute on Drug Abuse (NIDA).
Summary for Vanoxerine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 486 |
| WIPO Patent Applications | 248 |
| Japanese Patent Applications | 67 |
| Clinical Trial Progress | Phase 2 (2015-09-01) |
| Vendors | 0 |
Recent Clinical Trials for Vanoxerine
| Title | Sponsor | Phase |
|---|---|---|
| Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm | Laguna Pharmaceuticals, Inc. | Phase 3 |
| Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm | Laguna Pharmaceuticals, Inc. | Phase 2 |
| Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals | University of Texas | Phase 1 |
Clinical Trial Summary for Vanoxerine
Top disease conditions for Vanoxerine
Top clinical trial sponsors for Vanoxerine
US Patents for Vanoxerine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
